Literature DB >> 8949649

Nucleoside-nucleotide free diet protects rat colonic mucosa from damage induced by trinitrobenzene sulphonic acid.

A A Adjei1, T Morioka, C K Ameho, K Yamauchi, A D Kulkarni, H M Al-Mansouri, A Kawajiri, S Yamamoto.   

Abstract

BACKGROUND: Growing evidence suggests that intestinal recovery from injury induced by radiation, endotoxin, and protein deficiency is improved by the ingestion of nucleosides and nucleotides. AIM: This study examined the effect of dietary nucleosides and nucleotides supplementation on trinitrobenzene sulphonic acid induced colonic damage in experimental colitis.
METHODS: Sprague-Dawley rats were randomised into two groups and fed nucleic acid free 20% casein diet (control) or this diet supplemented with 0.5% nucleoside-nucleotide mixture for four weeks. On the second week, colonic inflammation was induced in rats by intracolonic administration of 0.25 ml of 50% ethanol containing 25 mg of trinitrobenzene sulphonic acid. Additionally, other sets of rats were treated with 0.25 ml of 50% ethanol, 25 mg of trinitrobenzene sulphonic acid in 0.25 ml saline, or 0.25 ml of 0.9% saline.
RESULTS: After two weeks, colon weight, macroscopic and microscopic damage scores, were significantly greater (p < 0.05) in the nucleoside-nucleotide supplemented group compared with the non-supplemented control groups. The same variables seen in the trinitrobenzene sulphonic acid-ethanol group fed nucleoside-nucleotide free diet were greater (p < 0.05) than in the rest of the groups fed nucleoside-nucleotide free diet and treated with ethanol, trinitrobenzene sulphonic acid in saline, or saline. Histologically, segmental ulceration and inflammation associated with significantly increased infiltration of polymorphonuclear leucocytes, macrophages, lymphocytes, fibroblasts were observed in the supplemented group compared with the controls. In the nucleoside-nucleotide supplemented group the epithelial damage, mucosal erosion, oedema, and coagulative necrosis of the muscularis propria was more extensive in comparison to the non-supplemented control groups.
CONCLUSIONS: This study suggests that dietary nucleosides and nucleotides may aggravate colonic damage and inflammation in chemically induced experimental colitis in rats; and that nucleoside-nucleotide free diet combined with other pharmacological agents may offer a better response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949649      PMCID: PMC1383351          DOI: 10.1136/gut.39.3.428

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  Ten years' experience with an elemental diet in the management of Crohn's disease.

Authors:  K Teahon; I Bjarnason; M Pearson; A J Levi
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

2.  Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease.

Authors:  M H Giaffer; G North; C D Holdsworth
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

Review 3.  Gene expression in the intestine: the effect of dietary nucleotides.

Authors:  N S LeLeiko; M J Walsh; S Abraham
Journal:  Adv Pediatr       Date:  1995

4.  Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.

Authors:  H Allgayer; K Deschryver; W F Stenson
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

5.  Effect of dietary nucleotides on intestinal repair in rats with experimental chronic diarrhea.

Authors:  M C Nuñez; M V Ayudarte; D Morales; M D Suarez; A Gil
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Nov-Dec       Impact factor: 4.016

6.  Nutritional issues in pediatric inflammatory bowel disease.

Authors:  E Seidman; N LeLeiko; M Ament; W Berman; D Caplan; J Evans; S Kocoshis; A Lake; K Motil; J Sutphen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-05       Impact factor: 2.839

7.  Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis.

Authors:  J Vilaseca; A Salas; F Guarner; R Rodríguez; M Martínez; J R Malagelada
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 8.  The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection.

Authors:  W W Souba; V S Klimberg; D A Plumley; R M Salloum; T C Flynn; K I Bland; E M Copeland
Journal:  J Surg Res       Date:  1990-04       Impact factor: 2.192

9.  Effect of dietary nucleosides on growth and maturation of the developing gut in the rat.

Authors:  R Uauy; G Stringel; R Thomas; R Quan
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-05       Impact factor: 2.839

10.  Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.

Authors:  A H Raouf; V Hildrey; J Daniel; R J Walker; N Krasner; E Elias; J M Rhodes
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

View more
  4 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

2.  Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis.

Authors:  C K Ameho; A A Adjei; E K Harrison; K Takeshita; T Morioka; Y Arakaki; E Ito; I Suzuki; A D Kulkarni; A Kawajiri; S Yamamoto
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

3.  Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate.

Authors:  Angela K Moss; Sulaiman R Hamarneh; Mussa M Rafat Mohamed; Sundaram Ramasamy; Halim Yammine; Palak Patel; Kanakaraju Kaliannan; Sayeda N Alam; Nur Muhammad; Omeed Moaven; Abeba Teshager; Nondita S Malo; Sonoko Narisawa; José Luis Millán; H Shaw Warren; Elizabeth Hohmann; Madhu S Malo; Richard A Hodin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

4.  Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?

Authors:  Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.